Clinical Trial Update: WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether lowering the aspirin dose improves outcomes when added to rivaroxaban in chronic coronary syndrome patients; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Aspirin (Aspirin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2026-02-20